Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             91 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors Miwa, Shinji

12 p. 2158-2165
artikel
2 A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer Hasegawa, Rikiya

12 p. 1574-1581
artikel
3 Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis Squires, Bryan S.

12 p. 2282-2294
artikel
4 An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer Tsuchiya, Tomohiro

12 p. 1596-1604
artikel
5 A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302) Tamura, Shigeyuki

12 p. 2035-2043
artikel
6 A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors Campos, Susana

12 p. 1881-1890
artikel
7 Assessment of button-type jejunostomy for nutritional management after esophagectomy in 201 cases Ishikawa, Yoshitaka

12 p. 2224-2228
artikel
8 Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis Washino, Satoshi

12 p. 1651-1658
artikel
9 Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study) Matsuoka, Hiroshi

12 p. 1859-1866
artikel
10 Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study Sugawara, Shunichi

12 p. 1828-1838
artikel
11 Can contralateral lymph-node metastases be ruled out in prostate cancer patients with only unilaterally positive prostate biopsy? Michalik, Bianca

12 p. 1659-1666
artikel
12 Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series Iwasawa, Tomohiro

12 p. 1867-1873
artikel
13 Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan Baba, Tomohisa

12 p. 1585-1596
artikel
14 Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study Son, Il Tae

12 p. 2237-2245
artikel
15 Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer Nomura, Hidetaka

12 p. 2331-2337
artikel
16 Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma Doi, Hiroshi

12 p. 1607-1615
artikel
17 Clinical impact of periodontal disease on postoperative complications in gastrointestinal cancer patients Nishikawa, Mao

12 p. 1558-1564
artikel
18 Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience Uchihara, Masaki

12 p. 2275-2281
artikel
19 Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma Kawata, Ryo

12 p. 1597-1606
artikel
20 Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience Zhu, Jun

12 p. 2144-2150
artikel
21 Combining nutritional status with TNM stage: a physiological update on gastric cancer staging for improving prognostic accuracy in elderly patients Sugawara, Kotaro

12 p. 1849-1858
artikel
22 Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer Akdeniz, Nadiye

12 p. 2015-2024
artikel
23 Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study) Shoji, Tadahiro

12 p. 1874-1880
artikel
24 Computed tomography-derived biomarker for predicting the treatment response to neoadjuvant chemoradiotherapy of rectal cancer Kurata, Yoshihiro

12 p. 2246-2254
artikel
25 Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial Mizokami, Atsushi

12 p. 1629-1631
artikel
26 Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study Sugawara, Shunichi

12 p. 1839-1840
artikel
27 Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy Imai, Yu

12 p. 1697
artikel
28 Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma Sano, Takeshi

12 p. 1573-1584
artikel
29 Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study Sunami, Kazutaka

12 p. 2151-2157
artikel
30 Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer Matsumiya, Hiroko

12 p. 2138-2143
artikel
31 Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma Tokuda, Kazunori

12 p. 2083-2089
artikel
32 Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer Kato, Masashi

12 p. 2130-2137
artikel
33 Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study Kawaguchi, Kansuke

12 p. 2122-2129
artikel
34 Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study Aoki, Tomokazu

12 p. 2205-2215
artikel
35 Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases Ninomiya, Mizuki

12 p. 2255-2264
artikel
36 First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048 Takahashi, Shunji

12 p. 1805-1817
artikel
37 FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study de Albuquerque Ribeiro Gondinho, Priscilla

12 p. 2066-2074
artikel
38 Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong Leung, Karen K. Y.

12 p. 1904-1915
artikel
39 Gastrectomy for invasive micropapillary carcinoma is associated with poorer disease-free and disease-specific survival Kano, Mikihiro

12 p. 1565-1573
artikel
40 Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index Osawa, Takahiro

12 p. 2090-2098
artikel
41 High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor Lei, Ting

12 p. 2025-2034
artikel
42 HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients Zhao, Xue-Feng

12 p. 2044-2054
artikel
43 Impact of prostate-specific antigen screening on tumor size in patients with prostate cancer in a super-aging district in Kyoto, Japan Matsugasumi, Toru

12 p. 2303-2309
artikel
44 Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients Ogata, Dai

12 p. 2338-2346
artikel
45 Intentions for catch-up HPV vaccination in Japan: an internet survey Nakagawa, Satoshi

12 p. 1667-1679
artikel
46 List of reviewers 2021–2022
12 p. 1916-1919
artikel
47 List of reviewers 2018–2019
12 p. 1632-1634
artikel
48 List of reviewers 2020–2021
12 p. 2355-2358
artikel
49 List of reviewers 2019–2020
12 p. 2179-2182
artikel
50 List of reviewers 2022–2023
12 p. 1698-1702
artikel
51 Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2 Ye, Jia

12 p. 1891-1903
artikel
52 Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma Yoshikawa, Nobuhisa

12 p. 1680-1689
artikel
53 Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer Beyan, Cengiz

12 p. 2175-2176
artikel
54 Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1 Kumamoto, Tadashi

12 p. 2161-2178
artikel
55 Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients Zhu, Linhui

12 p. 2194-2204
artikel
56 Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases Kamitani, Rei

12 p. 2099-2106
artikel
57 Oral frailty is a risk factor for body weight loss after gastrectomy: a single-center, retrospective study Teranishi, Ryugo

12 p. 1625-1632
artikel
58 Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database Abdel-Rahman, Omar

12 p. 1582-1587
artikel
59 Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan Ohta, Ryo

12 p. 2075-2082
artikel
60 Palbociclib as an early-line treatment for Japanese patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: a review of clinical trial and real-world data Masuda, Norikazu

12 p. 2179-2193
artikel
61 Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan Iwamoto, Hideto

12 p. 1588-1595
artikel
62 Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101) Yamaguchi, Masafumi

12 p. 2216-2223
artikel
63 Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302 Kasai, Takashi

12 p. 1841-1848
artikel
64 Phonatory function in patients with well-differentiated thyroid carcinoma following meticulous resection of tumors adhering to the recurrent laryngeal nerve Miyamaru, Satoru

12 p. 1536-1542
artikel
65 Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer Guo, Xiao-xiao

12 p. 2115-2121
artikel
66 Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center Chen, Shiqi

12 p. 1605-1611
artikel
67 Prognostic factors in cutaneous apocrine carcinoma: a single-institution retrospective study of 32 patients Tsuruta, Seiji

12 p. 1690-1696
artikel
68 Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors Jha, Jayanti

12 p. 1526-1535
artikel
69 Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan Uhara, Hisashi

12 p. 1508-1514
artikel
70 Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan Uhara, Hisashi

12 p. 1508-1514
artikel
71 Recent therapeutic strategies for metastatic melanoma: introduction to invited articles Yamamoto, Akifumi

12 p. 1507
artikel
72 Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020 Fukuokaya, Wataru

12 p. 2177-2178
artikel
73 Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study Utsumi, Takanobu

12 p. 2295-2302
artikel
74 Risk of metachronous colorectal cancer after colectomy for first colon cancer in Lynch syndrome: multicenter retrospective study in Japan Chikatani, Kenichi

12 p. 1633-1640
artikel
75 Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study Kondo, Shunsuke

12 p. 1795-1804
artikel
76 Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer Sawada, Mayumi

12 p. 1612-1619
artikel
77 Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient Miyazaki, Katsuki

12 p. 2265-2274
artikel
78 Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan Ohta, Tsuyoshi

12 p. 2318-2330
artikel
79 Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors Choi, Jung Yoon

12 p. 1515-1525
artikel
80 TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing Kawashima, Masumi

12 p. 2166-2174
artikel
81 The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma Liang, Shoulei

12 p. 2347-2354
artikel
82 The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study Makino, Tomoyuki

12 p. 2310-2317
artikel
83 The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancer Sun, Xia

12 p. 2229-2236
artikel
84 The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study Tohi, Yoichiro

12 p. 2107-2114
artikel
85 The predictive value of advanced lung cancer inflammation index for short-term outcomes and prognosis of colorectal cancer patients who underwent radical surgery Zhang, Bin

12 p. 1616-1624
artikel
86 Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis Masuda, Yuya

12 p. 1620-1628
artikel
87 Tumor–stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade Sakai, Toshihiko

12 p. 1818-1827
artikel
88 Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis Mori, Yoshiko

12 p. 1641-1650
artikel
89 Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan Sakai, Kosuke

12 p. 1549-1557
artikel
90 Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study Fukuizumi, Aya

12 p. 1543-1548
artikel
91 YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2 Bie, Qingli

12 p. 2055-2065
artikel
                             91 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland